Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685727 | 0.82 | ALDH1A1 (0.38) | ALDH1A1CYP2C19TSHRCYP3A4CYP2D6 | |
| SCHEMBL328665 | 0.81 | MAPK1 (0.47) | ALDH1A1CYP2C19CYP1A2CYP2C9MAPK1 | |
| SCHEMBL12914688 | 0.79 | MAPK1 (0.45) | ALDH1A1CYP2C19CYP1A2CYP2C9MAPK1 | |
| SCHEMBL685118 | 0.79 | ALDH1A1 (0.41) | ALDH1A1CYP2C19TSHRCYP3A4CYP2D6 | |
| SCHEMBL3806643 | 0.76 | ALDH1A1 (0.35) | ALDH1A1CYP2C19CYP1A2CYP2C9MAPK1 | |
| SCHEMBL3799178 | 0.75 | ALDH1A1 (0.37) | ALDH1A1CYP2C19CYP1A2CYP2C9MAPK1 | |
| SCHEMBL15256898 | 0.75 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL12121034 | 0.74 | ALDH1A1 (0.38) | ALDH1A1CYP2C19TSHRCYP3A4CYP2D6 | |
| SCHEMBL12998172 | 0.74 | ALDH1A1 (0.38) | ALDH1A1CYP2C19CYP1A2CYP2C9MAPK1 | |
| SCHEMBL13395831 | 0.73 | ALDH1A1 (0.36) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530134-B2 | Process for producing photoresist polymeric compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-8470510-B2 | Polymer for lithographic purposes and method for producing same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20110065044-A1 | POLYMER FOR LITHOGRAPHIC PURPOSES AND METHOD FOR PRODUCING SAME | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100297551-A1 | PROCESS FOR PRODUCING PHOTORESIST POLYMERIC COMPOUNDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | RRS1, CNKSR1, LSS | ALDH1A1 1413/4885CYP2C19 1525/4885CYP1A2 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.